|
FDA/CDC Partnership Addresses Unintentional Drug Overdosing
FDA has joined with the Centers for Disease Control and Prevention (CDC) in a new program of targeted support for research into the prevention of unintentional drug overdoses in adults. Unintentional poisoning is now the second leading cause of unintentional injury death for Americans, with 23,618 deaths in 2005. Of these, approximately 95% were due to drug overdoses, and more than half of these were associated with prescription drugs. Such overdoses can be the result of accidental overdose or abuse of drugs.
The CDC and FDA grants, which are broadly available to eligible public and private organizations, will be for research that evaluates novel approaches to drug overdose prevention. The focus of proposed research can be in a number of different areas, including evaluating the effectiveness of actions taken by the FDA or pharmaceutical companies to address problems associated with unintentional overdoses. The CDC and FDA partnership may increase total available FY 2009 funds and the estimated number of awards to be funded. The average amount of each award will not change.
Research of this type can help identify and refine strategies to reduce inappropriate use or abuse of these medications and assure that physicians and patients who need them, including patients with acute and chronic pain, have the best possible information available.
For additional information, including application materials, please see http://www.cdc.gov/od/pgo/funding/CE09-004.htm.
Back to Top
Back to Drug Information
 PDF requires the free
Adobe Acrobat Reader
Date created: January 22, 2009 |
